Treatment of locally advanced carcinomas of head and neck with intensity-modulated radiation therapy (IMRT) in combination with cetuximab and chemotherapy: the REACH protocol

BACKGROUND: Primary treatment of carcinoma of the oro-/hypopharynx or larynx may consist of combined platinum-containing chemoradiotherapy. In order to improve clinical outcome (i.e. local control/overall survival), combined therapy is intensified by the addition of the EGFR inhibitor cetuximab (Erb...

Descripción completa

Detalles Bibliográficos
Autores principales: Habl, Gregor, Jensen, Alexandra D, Potthoff, Karin, Uhl, Matthias, Hof, Holger, Hajda, Jacek, Simon, Christian, Debus, Jürgen, Krempien, Robert, Münter, Marc W
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001721/
https://www.ncbi.nlm.nih.gov/pubmed/21108850
http://dx.doi.org/10.1186/1471-2407-10-651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001721/
https://www.ncbi.nlm.nih.gov/pubmed/21108850
http://dx.doi.org/10.1186/1471-2407-10-651

Ejemplares similares